About Trabectedin

A recent publication on the safety and efficacy of trabectedin treatment for advanced sarcoma:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076042/

Partial response or stable disease was seen in 61% of synovial sarcoma patients (11 patients out of 18) in a phase II study.

Nik had strange side effects with this treatment… coughing up small amounts of blood and pnemonia in both lungs. Tumors continued to grow – we stopped after 2 rounds.